Identify three treatment options for the management of advanced renal cell carcinoma.
Identify the most common complications following radical cystectomy and the initial management of these complications.
Distinguish some of the key diagnoses in a family history that may warrant a referral to a genetic counselor and explain the role of genetic counseling and testing in the overall care of patients.
Identify three benefits of APP-led cancer survivorship clinics.
Describe the treatment options for penile cancer and management of potential complications from therapy.
Describe the imaging studies used in kidney stone patients along with the appropriate indications for imaging acute stone symptoms, postoperative care and disease surveillance.
Discuss bacterial resistance, describe the role of superbugs and Antibiotic Stewardship, and list alternative treatment options for UTIs.
List the factors associated with individual presentation of urologic chronic pelvic pain syndromes in men and select a treatment regimen.
Discuss the treatment care pathway for a patient with OAB who tries and fails conservative therapies, the risks and benefits of third line therapy and the opportunity to use combination OAB drug therapy in a patient with bothersome OAB symptoms.
Outline the surgical options for trans-feminine and trans-masculine people seeking gender-affirming genital surgery, as well as the needed preparation for these surgeries, expected outcomes, and complications.
* Describe the scope of an infertility evaluation and identify the treatments for common infertility-related disorders.
8:00 AM - 8:05 AM
8:05 AM - 9:05 AM
Personal and Professional Practice Management (Pearls: Collaborating Effectively with Your Team, Taking your Role to the Next Level & • Balancing Work/Life and Avoiding Burnout) Heather Schultz, NP – The University of North Carolina School of Med; James R. Kovarik, III, PA-C – University of Kansas Health System; Sara M. Drummer, APRN, FNP-BC, CUNP
9:05 AM - 9:20 AM
Panel Discussion Q&A
9:20 AM - 12:05 PM
Session IV: Voiding Dysfunction
9:21 AM - 9:30 AM
Session IV ARS Pre-Test
9:30 AM - 10:10 AM
The Resistance: UTIs and the Antibiotic Crisis Lori Guelman, APN – Stanford Urology
10:10 AM - 10:25 AM
10:25 AM - 11:05 AM
Urologic Chronic Pelvic Pain Syndromes and Men - How Do We Manage? Susanne Quallich, PhD, NP
11:05 AM - 11:45 AM
Female Pelvic Pain/Pelvic Floor Dysfunction A. Lenore Ackerman, MD
11:45 AM - 12:05 PM
Panel Discussion Q&A
12:05 PM - 1:20 PM
Latest Perspectives in Overactive Bladder (A Non-CME Lunch Symposium sponsored by Astellas Pharma US, Inc.)
1:20 PM - 2:35 PM
Session IV (continued)
1:21 PM - 2:20 PM
Update on the Overactive Bladder Management Guidelines Sandip Prasan Vasavada, MD – Cleveland Clinic Foundation
2:20 PM - 2:35 PM
Session IV: Panel Discussion Q&A and ARS Post-test
2:35 PM - 3:40 PM
Session V: Reconstructive Urology
2:36 PM - 2:45 PM
Session V: ARS Pre-test
2:45 PM - 3:25 PM
Gender-affirming Genital Surgery for the APP Daniel David Dugi, III, MD
3:25 PM - 3:40 PM
Session V: Panel Discussion Q&A and ARS Post-test
3:40 PM - 3:55 PM
3:55 PM - 5:00 PM
Session VI: Infertility
3:56 PM - 4:05 PM
Session VI: ARS Pre-test
4:05 PM - 4:45 PM
Evaluation and Management of the Sub-fertile Male: Everything You Always Wanted to Know but Have Been Afraid to Ask Aaron Jeremy Milbank, MD – Metro Urologic Specialists
4:45 PM - 5:00 PM
Session VI: Panel Discussion Q&A and ARS Post-test